13F Portfolios

EcoR1 Capital, LLC: CG ONCOLOGY INC (CGON): Quarterly 13F Position History

As of Q1 2026, EcoR1 Capital, LLC reported 1,102,000 shares of CG ONCOLOGY INC (CGON), worth $74.6M and representing 3.2% of its 13F equity book. Quarter-over-quarter share count change: + 330,000 (+42.7%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.

Recent initiation: EcoR1 Capital, LLC first reported CGON on the Q4 2025 filing — fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 1,102,000 +330,000 +42.7% $74.6M 3.2% $67.7
Q4 2025 772,000 $32.1M 1.5% $41.5

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did EcoR1 Capital, LLC first disclose a CGON position in 13F-HR filings?

EcoR1 Capital, LLC first reported CG ONCOLOGY INC (CGON) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was EcoR1 Capital, LLC's most recent quarter-over-quarter share-count change in CGON?

Between Q4 2025 and Q1 2026, EcoR1 Capital, LLC added 330,000 shares of CGON (+42.7%), bringing the total reported position to 1,102,000 shares at a market value of $74.6M.

Does the implied price-per-share represent EcoR1 Capital, LLC's cost basis in CGON?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.